RVMD Revolution Medicines, Inc. · NASDAQ · Biological Products, (No Diagnostic Substances)
What each lens says: insiders — insiders bought $0.0M and sold $33.3M in 30 days (0 buys, 37 sales) · funds — Duquesne (Druckenmiller) opened or grew
no price series yet
What the readers say — 0 reads of posts over 50 upvotes, last 30 days
no reads yet — the model key is not set on the server
posts per day (height) and word-score mood (color), gated
Connected to RVMD — asked of the layer, served live
funds.holdings
- references ×2 13f:0001536411-26-000004:76155X100
- references ×1 13f:0001536411-26-000006:76155X100
funds.securities
- references ×1 REVOLUTION MEDICINES INC
insiders.trades
- references ×1 form4:0001193125-26-388156:0
- references ×1 form4:0001193125-26-388156:1
- references ×1 form4:0001193125-26-388156:2
- references ×1 form4:0001193125-26-388156:3
- references ×1 form4:0001193125-26-388156:4
- references ×1 form4:0001193125-26-388156:5
- references ×1 form4:0001193125-26-388156:6
- references ×1 See Remarks
- references ×1 See Remarks
- references ×1 Chief Operating Officer
- references ×1 Chief Operating Officer
- references ×1 See Remarks
news.articles
- references ×8 Revolution Medicines Got Its Breakthrough—What Moves It Next?
- references ×4 Revolution Medicines (NASDAQ: RVMD) trust moves to sell 73,090 shares
- references ×1 Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy?
- references ×14 Pancreatic Cancer Drug Milestone Affirms Why Revolution Medicines Inc. (RVMD) is a Hot Sto
- references ×4 Revolution Medicines (RVMD) exec sells 1,774 shares, keeps 39,575 RSUs
- references ×1 Revolution Medicines COO Margaret Horn sells $989,612 of common stock By Investing.com
- references ×3 Revolution Medicines nears lease for 700,000-square-foot Redwood City campus
- references ×5 An experimental lung cancer drug held disease in check for 89% of patients in one group.
- references ×4 Morgan Stanley initiates Revolution stock with overweight on Rasonque approval
History of RVMD — the layer's log: every relationship that appeared, strengthened or faded
- 2026-10-01 06:37 appeared references news:d829b55bdb55596b news.articles · crossed the bar · ×1
- 2026-10-01 06:36 appeared references news:ec03db749e21d494 news.articles · crossed the bar · ×1
- 2026-10-01 06:36 appeared references news:4ca2da17acd00129 news.articles · crossed the bar · ×1
- 2026-10-01 06:36 appeared references news:83072363d679755b news.articles · crossed the bar · ×1
- 2026-09-28 23:06 appeared references form4:0002124509-26-000012:1 insiders.trades · crossed the bar · ×1
- 2026-09-28 23:06 appeared references form4:0002124509-26-000012:0 insiders.trades · crossed the bar · ×1
- 2026-09-26 20:31 strengthened references 13f:0001536411-26-000004:76155X100 funds.holdings · ×2
- 2026-09-24 14:23 strengthened references news:b296903b5f3ebcea news.articles · ×4
- 2026-09-24 14:23 strengthened references news:6b95111be0365d6c news.articles · ×2
- 2026-09-24 14:23 strengthened references news:555c6c7783682b8e news.articles · ×2
- 2026-09-23 02:27 strengthened references news:f06e2333c7b30d8f news.articles · ×2
- 2026-09-23 02:27 appeared references news:294b76039e0553ec news.articles · crossed the bar · ×1
- 2026-09-23 02:27 appeared references news:ceec14a0ecc4b783 news.articles · crossed the bar · ×1
- 2026-09-23 02:27 strengthened references news:0577b723cb4e2764 news.articles · ×4
- 2026-09-23 02:27 strengthened references news:c2b42a74b31a167a news.articles · ×4
- 2026-09-23 02:27 strengthened references news:9aa79ad849503497 news.articles · ×4
- 2026-09-23 02:27 strengthened references news:0b4e5ca9d93a3420 news.articles · ×4
- 2026-09-23 02:27 strengthened references news:45046b766b9d94dd news.articles · ×4
- 2026-09-23 02:27 strengthened references news:345e171d3c360ae2 news.articles · ×16
- 2026-09-23 02:27 strengthened references news:df67c260c10967b6 news.articles · ×2
- 2026-09-23 02:27 appeared references news:555c6c7783682b8e news.articles · crossed the bar · ×1
- 2026-09-23 02:27 appeared references news:6b95111be0365d6c news.articles · crossed the bar · ×1
- 2026-09-22 22:09 appeared references form4:0002124509-26-000010:0 insiders.trades · crossed the bar · ×1
The reads — each post's actual stance, by a language model
no reads yet for this ticker
Reddit posts — over 50 upvotes
| post | ⬆ | flair | word score |
|---|---|---|---|
| no gated posts yet | |||
The comments — loudest in 30 days, over 10 upvotes
no loud comments naming this ticker yet
News
Who holds it — the big funds' 13F reports, each manager's newest quarter
| manager | position | shares | move vs prior quarter | as of |
|---|---|---|---|---|
| Duquesne (Druckenmiller) | $0M | 399,587 | increased | 2026-06-30 |
Insider trades — Form 4 open-market buys and sales
| traded | filed | who | side | shares | price | value |
|---|---|---|---|---|---|---|
| 2026-09-25 | 2026-09-28 | Mancini Anthony See Remarks | sell | 3,121 | $200.54 | $625,885 |
| 2026-09-24 | 2026-09-28 | Mancini Anthony See Remarks | sell | 587 | $200.00 | $117,400 |
| 2026-09-18 | 2026-09-22 | Mancini Anthony See Remarks | sell | 1,764 | $196.94 | $347,402 |
| 2026-09-16 | 2026-09-18 | Horn Margaret A Chief Operating Officer | sell | 76 | $195.01 | $14,821 |
| 2026-09-16 | 2026-09-18 | Horn Margaret A Chief Operating Officer | sell | 4,891 | $199.30 | $974,792 |
| 2026-09-16 | 2026-09-18 | GOLDSMITH MARK A See Remarks | sell | 213 | $195.01 | $41,537 |
| 2026-09-16 | 2026-09-18 | GOLDSMITH MARK A See Remarks | sell | 13,775 | $199.30 | $2,745,402 |
| 2026-09-16 | 2026-09-18 | Cislini Jeff SVP & General Counsel | sell | 52 | $195.01 | $10,140 |
| 2026-09-16 | 2026-09-18 | Cislini Jeff SVP & General Counsel | sell | 3,314 | $199.30 | $660,491 |
| 2026-09-16 | 2026-09-18 | Anders Jack Chief Financial Officer | sell | 61 | $195.00 | $11,895 |
| 2026-09-16 | 2026-09-18 | Anders Jack Chief Financial Officer | sell | 3,992 | $199.30 | $795,618 |
| 2026-09-16 | 2026-09-18 | Sandler Alan B. Chief Development Officer | sell | 5 | $194.96 | $975 |
| 2026-09-16 | 2026-09-18 | Sandler Alan B. Chief Development Officer | sell | 336 | $199.30 | $66,966 |
| 2026-09-16 | 2026-09-18 | Mancini Anthony See Remarks | sell | 27 | $195.05 | $5,266 |
| 2026-09-16 | 2026-09-18 | Mancini Anthony See Remarks | sell | 1,747 | $199.30 | $348,183 |
| 2026-09-16 | 2026-09-18 | Kelsey Stephen Michael See Remarks | sell | 85 | $195.01 | $16,576 |
| 2026-09-16 | 2026-09-18 | Kelsey Stephen Michael See Remarks | sell | 5,484 | $199.30 | $1,092,979 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 800 | $198.55 | $158,840 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 11,833 | $200.11 | $2,367,955 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 13,368 | $200.78 | $2,683,986 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 21,447 | $201.75 | $4,326,947 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 18,869 | $203.06 | $3,831,550 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 17,949 | $203.87 | $3,659,309 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 4,995 | $204.84 | $1,023,189 |
| 2026-09-11 | 2026-09-15 | Kelsey Stephen Michael See Remarks | sell | 3,270 | $205.81 | $672,991 |
| 2026-09-10 | 2026-09-14 | Mancini Anthony See Remarks | sell | 6,019 | $203.28 | $1,223,569 |
| 2026-09-10 | 2026-09-14 | Mancini Anthony See Remarks | sell | 5,530 | $204.14 | $1,128,870 |
| 2026-09-10 | 2026-09-14 | Mancini Anthony See Remarks | sell | 2,420 | $205.05 | $496,224 |
| 2026-09-10 | 2026-09-14 | Mancini Anthony See Remarks | sell | 1,179 | $206.10 | $242,991 |
| 2026-09-10 | 2026-09-14 | Mancini Anthony See Remarks | sell | 300 | $207.17 | $62,152 |
Congressional trades — House periodic transaction reports
| traded | filed | member | type | owner | amount |
|---|---|---|---|---|---|
| no filings naming this ticker in the window | |||||